A Phase 1b, Open-label Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activities of IN10018 as Monotherapy and Combination Therapy in Subjects with Metastatic Melanoma
- Shackleton, Mark (Primary Chief Investigator (PCI))
- Hawkins, Cheryl-Ann, (Project Manager)
Project: Research